Summary. The oral oestrogenic activity of AY-11483 has been compared to that of oestriol and mestranol. The compound shows significant activity in the vaginal cornification test in rats and mice; however, it has a relatively weak effect in the uterotrophic assay in rats, mice and rabbits. Furthermore, like oestriol, it exerts a weak effect on the endometrium in rabbits. Based on our findings, AY-11483 should be classified as an impeded oestrogen with possible clinical application.
INTRODUCTION
The physiological importance of oestrogens and their effect on fertility are well known. A new class of oestrogens was described by Huggins & Jensen (1955) which they called "impeded estrogens". The characteristics of this type of compound are: a shallow dose-response curve in the uterotrophic assay and the inhibition of the uterine growth-promoting effect of oestrone. Oestriol is the prototype of the impeded oestrogens and is known to exert a weak effect on the uterus, both in animal experiments (Merill, 1958; Puck & Hübner, 1956; Overbeek & de Visser, 1958) and in the human (Puck & Hübner, 1957; Borglin, 1959) . Furthermore, Haskins, Moszkowski & Whitelock (1968) A series of seventeen substituted oestradiol derivatives was synthesized and tested (Lefebvre, Marshall, Revesz, Banik & Deghenghi, 1967) in our labora¬ tories, of which 3-acetoxy-17a-[3-furyl]-l,3,5(10)-7-oestratetraen-17-ol (AY-11483) was investigated in detail. The contraceptive effect of this compound in rats was reported in a previous communication (Banik, Revesz & Herr, 1969) . The purpose of this paper is to describe some oestrogenic parameters of AY-11483 Vaginal cornification test (Allen-Doisy test) The method described by Allen & Doisy (1923) was used with a slight modification (Revesz & Chappel, 1966) 325 g) and mice (25 to 30 g). The ED50 was the total dose which induced vaginal cornification in 50% of the animals.
Uterotrophic assay
Rats and mice. This test was carried out in intact 22-to 23-day-old rats weigh¬ ing 34 to 42 g (Dorfman & Dorfman, 1954) and in mice weighing 11 to 15 g (Rubin, Dorfman, Black & Dorfman, 1951) . Compounds were administered once daily for 3 consecutive days, the uteri were dissected out 24 hr after the last injection and weighed following the removal of the intraluminal fluid by blotting on filter paper.
Rabbits. Immature female rabbits weighing 900 to 1100 g were treated once every 2nd day over a period of 5 days (total of three doses). On the 6th day, the animals were killed, the uterine weights determined and results expressed as mg per 100 g of body weight.
Effect on the endometrium in immature rabbits
In the classical Clauberg assay (Clauberg, 1930) 
DISCUSSION
Although the oestrogenicity of a substance can be determined by a number of bioassays (Emmens, 1962) , the vaginal cornification test of Allen & Doisy (1923) in ovariectomized rats and mice is perhaps the most specific assay for oestrogenicity. According to Astwood (1965) , an oestrogen is defined as a substance which produces a confined vaginal smear in the spayed animal. By contrast, the uterotrophic assay in immature rats or mice is less specific for oestrogenicity since androgens, progestins and even desoxycorticosterone (Velardo, 1959) Since AY-11483 gave a shallow dose-response curve like oestriol in the utero¬ trophic assay in rats and mice, this compound could also be classified as an "impeded estrogen" (Huggins & Jensen, 1955) . Like oestriol, AY-11483 also has anti-oestrogenic action (Revesz, 1969, unpublished data) which is another property of an impeded oestrogen.
The present experiments indicate that AY-11483 is a potent orally active oestrogen in the vaginal cornification test in rats and mice with weak effect on the uterine weight in rats, mice and rabbits and endometrium in rabbits. In view of the strong oestrogenicity in the vaginal cornification assay and the weak effect on the uterus, AY-11483 might be a useful drug in the menopausein particular where fibroids are present-when stimulation of the uterus is undesirable. Furthermore, the weak effect of the compound on the myometrium and endometrium might be an advantage over the conventional combination of oestrogens with progestins for contraception.
